The MarketWatch News Department was not involved in the creation of this content. -- This is a randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy, ...
Spanish international pharmaceutical company Ferrer has announced the completion of patient recruitment for the PROSPER study, a Phase II clinical trial designed to assess the efficacy, safety, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback